Variant report
Variant | nsv1022048 |
---|---|
Chromosome Location | chr5:99249466-99271946 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10515290 | chr5:99249466-99249467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs572409323 | chr5:99249467-99249468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546295546 | chr5:99249471-99249472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17167409 | chr5:99249499-99249500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs150217640 | chr5:99249508-99249509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544110830 | chr5:99249536-99249537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573463677 | chr5:99249578-99249579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562408453 | chr5:99249635-99249636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11750350 | chr5:99249694-99249695 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs2616322 | chr5:99249718-99249719 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs138998087 | chr5:99249835-99249836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs66731403 | chr5:99249837-99249838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17750372 | chr5:99249876-99249877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186161003 | chr5:99249881-99249882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78619437 | chr5:99249934-99249935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116362847 | chr5:99249938-99249939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569727676 | chr5:99249944-99249945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536887446 | chr5:99249948-99249949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555241411 | chr5:99249964-99249965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75814834 | chr5:99250051-99250052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115767974 | chr5:99250092-99250093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376526783 | chr5:99250094-99250095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116145438 | chr5:99250107-99250108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149370478 | chr5:99250124-99250125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545960231 | chr5:99250144-99250145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145781489 | chr5:99250160-99250161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576549677 | chr5:99250183-99250184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191152011 | chr5:99250212-99250213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562270486 | chr5:99250255-99250256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529330563 | chr5:99250268-99250269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114641617 | chr5:99250294-99250295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2924607 | chr5:99250297-99250298 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs545835219 | chr5:99250309-99250310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1161336 | chr5:99250323-99250324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs182532688 | chr5:99250324-99250325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs80111877 | chr5:99250349-99250350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530689903 | chr5:99250365-99250366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571811888 | chr5:99250395-99250396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533891171 | chr5:99264217-99264218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1161327 | chr5:99264322-99264323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs192983994 | chr5:99264335-99264336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183662818 | chr5:99264338-99264339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143078678 | chr5:99264352-99264353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574647403 | chr5:99264371-99264372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536606321 | chr5:99264380-99264381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554557938 | chr5:99264398-99264399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572971416 | chr5:99264448-99264449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1161326 | chr5:99264455-99264456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553416692 | chr5:99264477-99264478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188191678 | chr5:99264509-99264510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99248600-99250400 | Enhancers | H1 Cell Line | embryonic stem cell |
2 | chr5:99264200-99264400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr5:99264400-99265600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr5:99265400-99266000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:99265600-99265800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |